MRNX (Defiance Daily Target 2X Long MRNA ETF) Stock Analysis - SEC Filings

Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find MRNX SEC filings?

Rallies organizes MRNX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

MRNX Key Metrics

Key financial metrics for MRNX
MetricValue
Price$27.10
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume171.29K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MRNX News

MRNX Analyst Consensus

MRNX analyst coverage data. Average price target: $0.00.

Common questions about MRNX

Where can I find MRNX SEC filings?
Rallies organizes MRNX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show MRNX 10-K and 10-Q filings?
Rallies organizes MRNX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is MRNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRNX. It does not provide personalized investment advice.
MRNX

MRNX